Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-023030 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 27, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
180,000
Total Value
$0.00
P&L
+inf% (+$5,819,400.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Jan 12, 2026 | Grant/Award | 180,000 | $0.00 | $0.00 | 180,000 | Direct | โ | View Details |